Fighting Cancer Network vs. Breast Cancer [BC] Utilizzo e statistiche
This version of the Fighting Cancer Network App is limited to Breast Cancer and Prostate Cancer. Other cancers will be added over time. Fighting Cancer Network app is designed to provide actionable knowledge to cancer patients, caregivers, and others who desire to understand a diagnosis and treatment options using highly produced, short videos. The videos are curated to your cancer based on answers to a simple set of questions. The app also includes helpful features such as NOTES for your physicians, Journal called “My Story” which allows you to share and communicate with your friends and family, a Glossary of terms, and medication reminder.
A patient armed with knowledge will be better prepared to make decisions about treatment options, communicate with your doctor, and become better acquainted with the diagnostics, procedures systemic treatments, and radiation therapy you can expect in your cancer journey.
The NOTES feature allows you to keep track of questions you may have for your physician or things to share with your spouse, family or friends.
The My Story feature provide the opportunity to keep a journal of your cancer experience. Each entry can be saved as a private note, or shared with invited family and friends to help in communicating to the many people concerned about your condition.
The Glossary provides in-depth information about some of the terms used in your cancer journey. Understanding complicated or even unfamiliar terms helps in your ability to comprehend the important information from the video library.
Disclaimer: Fighting Cancer Network (FCN) does not diagnose, treat, or advise medical patients. FCN content is educational and intended to increase understanding and engagement of patients with their own physicians. Our information is supplied by physicians who follow such nationally accepted guidelines as NCCN.org and www.cancer.gov
- App Store di Apple
- Gratis
- Salute e fitness
Classifica degli store
- -
Breast Cancer @Point of Care for clinicians provides a well-engineered clinical decision support tool for you to obtain timely medical content and news as well as earning CME/CE credits, completely free of charge. If used in conjunction with our PRO Patient line of apps for patients (35+ apps for major conditions), Suite can provide you meaningful insights into between-visit patient progress—driving better decisions, better outcomes, and better care.
The app features Ask Cognitive™, an AI-assisted search technology to easily access curated, evidence-based, and disease-specific medical content. Clinicians can navigate content by asking voice-enabled natural language questions or typing them in. The Ask Cognitive confidence-rated answers efficiently incorporate the best current treatment options so decisions can be reached confidently and more rapidly, helping to improve patient outcomes. Answers can also be further investigated for deeper dives.
Features:
• Continually updated breast cancer content from expert physician authors
• Customize library with over 50 therapeutic areas to choose from
• Topics in diagnosis, treatment, and care management
• Case studies, videos, and interviews
• Access to actionable patient-recorded data
• Detailed reference list with access to original sources
• Continuing medical education credit (CME/CE) free of charge
• Surveys and peer polling
• Patient education resources to share with patients
Breast Cancer @Point of CareTM is designed to:
• Support discovery and practice change
• Provide relevant, evidence-based disease-specific medical content
• Improve patient outcomes at the point of care
Target Audience:
This CME/CE program is intended for oncologists, obstetrician-gynecologists, radiologists, primary care clinicians, physician assistants, nurses, nurse practitioners, pharmacists, and other oncology healthcare team members that treat and care for patients with breast cancer.
- App Store di Apple
- Gratis
- Settore Medico
Classifica degli store
- -
Fighting Cancer Network VS. 
Breast Cancer [BC]gennaio 15, 2026